HAMPTON HOSPITAL
1. Target Overview & Investment Thesis
HAMPTON HOSPITAL is a 120-bed suburban community hospital in BURLINGTON, NJ with $33.0M in net patient revenue and a 2.5% operating margin. The hospital serves a payer mix of 11.8% Medicare, 0.1% Medicaid, and 88.1% commercial.
Thesis: Undervalued. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.5% to 9.8% (+736bps).
| Net Revenue HCRIS | $33.0M |
| Current EBITDA COMPUTED | $810K |
| Operating Margin COMPUTED | 2.5% |
| Occupancy HCRIS | 78.6% |
| Revenue / Bed COMPUTED | $275K |
| Net-to-Gross HCRIS | 49.2% |
| Distress Probability ML | 43.4% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of 2.5% places it above the state median. Among 52 size-comparable peers (60-240 beds), the median margin is -8.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (60-240), prioritizing same-state peers. 52 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HAMPTON HOSPITAL (Target) | NJ | 120 | $33.0M | 2.5% |
| CAPITAL HEALTH MED CENTER - HO | NJ | 209 | $746.8M | 0.8% |
| PRINCETON HEALTHCARE SYSTEM | NJ | 206 | $587.8M | -5.7% |
| MONMOUTH MEDICAL CENTER | NJ | 240 | $448.7M | -10.8% |
| HELENE FULD MEDICAL CENTER | NJ | 162 | $430.2M | -3.2% |
| HUNTERDON MEDICAL CENTER | NJ | 184 | $358.4M | -9.6% |
| CENTRASTATE MEDICAL CENTER | NJ | 240 | $307.8M | -23.2% |
| MOUNTAINSIDE HOSPITAL | NJ | 184 | $306.3M | 12.2% |
| ST. CLARES HOSPITAL | NJ | 217 | $291.4M | -0.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $692K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $659K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $652K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $401K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $21K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $810K |
| + RCM Uplift | +$2.4M |
| Pro Forma EBITDA | $3.2M |
| Current Margin | 2.5% |
| Pro Forma Margin | 9.8% |
| WC Released (1x) | $1.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.2M | $29.6M | 23.75x | 88.4% |
| Base (11x exit) | 10.0x | 11.0x | $1.2M | $33.0M | 26.44x | 92.5% |
| Bull Case | 9.0x | 11.0x | $1.1M | $41.4M | 36.88x | 105.8% |
| Bull (12x exit) | 9.0x | 12.0x | $1.1M | $45.5M | 40.53x | 109.7% |
| Bear Case | 11.0x | 10.0x | $1.4M | $17.1M | 12.45x | 65.6% |
| Bear (11x exit) | 11.0x | 11.0x | $1.4M | $19.2M | 14.02x | 69.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 52 hospitals with 60-240 beds
- Same-state prioritization (n=53)
- Comp margins: P25=-25.6% / P50=-8.2% / P75=1.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.